Marc Levivier
Overview
Explore the profile of Marc Levivier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
255
Citations
2700
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Balossier A, Sahgal A, Kotecha R, Fariselli L, Gorgulho A, Levivier M, et al.
Neuro Oncol
. 2023 Dec;
26(3):429-443.
PMID: 38134966
Background: The choice of an appropriate strategy for intracanalicular vestibular schwannoma (ICVS) is still debated. We conducted a systematic review and meta-analysis with the aim to compare treatment outcomes amongst...
12.
Fleury V, Romascano D, Schneider D, Tuleasca C, Lorton O, Tomkova E, et al.
Stereotact Funct Neurosurg
. 2023 Nov;
101(6):380-386.
PMID: 37918368
We report the case of a 67-year-old left-handed female patient with disabling medically refractory essential tremor who underwent successful right-sided magnetic resonance-guided focused ultrasound (MRgFUS) of the ventral intermediate nucleus...
13.
Peters D, Asher A, Conti A, Schiappacasse L, Daniel R, Levivier M, et al.
Neurosurg Rev
. 2023 Oct;
46(1):287.
PMID: 37897519
Perioptic meningiomas, defined as those that are less than 3 mm from the optic apparatus, are challenging to treat with stereotactic radiosurgery (SRS). Tumor control must be weighed against the...
14.
Tuleasca C, Kotecha R, Sahgal A, de Salles A, Fariselli L, Paddick I, et al.
J Neurooncol
. 2023 Oct;
165(1):1-20.
PMID: 37843727
Purpose: To perform a systematic review of literature specific to single-fraction stereotactic radiosurgery (SRS) for large vestibular schwannomas (VS), maximum diameter ≥ 2.5 cm and/or classified as Koos Grade IV,...
15.
Belouaer A, Cossu G, Papadakis G, Gaudet J, Perez M, Chanez V, et al.
Acta Neurochir (Wien)
. 2023 Sep;
165(11):3137-3145.
PMID: 37688648
Background: Over the past decade, Enhanced Recovery After Surgery (ERAS®) guidelines have been proven to simplify postoperative care and improve recovery in several surgical disciplines. The authors set out to...
16.
Zubatkina I, Toma-Dasu I, Dasu A, Levivier M, Tuleasca C, Ivanov P
Neurosurgery
. 2023 Sep;
94(2):423-430.
PMID: 37665222
Background And Objectives: Brain metastases (BM) develop in nearly half of the patients with advanced melanoma. The aim of this retrospective historical cohort study was to analyze radiological response of...
17.
Diaz S, Reyns N, Ozduman K, Levivier M, Schulder M, Tuleasca C
Neurosurg Rev
. 2023 Sep;
46(1):217.
PMID: 37656287
Cingulate gyrus gliomas are rare among adult, hemispheric diffuse gliomas. Surgical reports are scarce. We performed a systematic review of the literature and meta-analysis, with the aim of focusing on...
18.
Peters D, Halimi F, Ozduman K, Levivier M, Conti A, Reyns N, et al.
Neurosurg Rev
. 2023 Jul;
46(1):185.
PMID: 37498398
Independently, both 5-aminolevulinic acid (5-ALA) and intraoperative neuromonitoring (IONM) have been shown to improve outcomes with high-grade gliomas (HGG). The interplay and overlap of both techniques are scarcely reported in...
19.
Vellayappan B, Lim-Fat M, Kotecha R, de Salles A, Fariselli L, Levivier M, et al.
Int J Radiat Oncol Biol Phys
. 2023 Jul;
118(1):14-28.
PMID: 37482137
Radiation necrosis (RN) secondary to stereotactic radiosurgery is a significant cause of morbidity. The optimal management of corticosteroid-refractory brain RN remains unclear. Our objective was to summarize the literature specific...
20.
Tuleasca C, Toma-Dasu I, Duroux S, George M, Maire R, Daniel R, et al.
Neurosurgery
. 2023 Jul;
94(1):174-182.
PMID: 37431994
Background And Objectives: Stereotactic radiosurgery (SRS) is a useful alternative for small- to medium-sized vestibular schwannoma. To evaluate whether biologically effective dose (BED Gy2.47 ), calculated for mean (BED Gy2.47...